Cancer Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2023-08-10 ms2000000595364248 来自陕西省

垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2023-07-31 ms7000000141590244 来自福建省

偏重的研究方向：肿瘤
经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2023-02-08 ms1000000302991030 来自浙江省

2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。

30 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-10-31 ms5000000132216544

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;生信+验证
经验分享：10.7投稿，过了查重
10.8等待编辑分配
10.14催了一次稿
10.21 under review
10.29 pending decision

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-12-06 ms7000001058021119 来自湖南省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-10-31 Dream_happyer

审稿速度:6.0 | 投稿命中率:5.0
经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-10-11 ms7000001058021119

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿

19 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-08-18 ms6000001444239145

审稿快不快啊？怎么有些人说快，有些说很慢

21 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-06-19 摩西摩西

偏重的研究方向：乳腺癌
经验分享：收纯临床回顾性分析文章吗？

16 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152126, encodeId=7b602152126cf, content=垃圾期刊，拖了我5个月然后拒了我的文章审稿人明明意见还可以，编辑最后毕了我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46435727444, createdName=ms2000000595364248, createdTime=Thu Aug 10 16:55:32 CST 2023, time=2023-08-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2150691, encodeId=c261215069186, content=偏重的研究方向：肿瘤 经验分享：5.19返回审稿意见，大修 6.11修回中途状态变成under review，然后pending recommendation，就卡这了，6周了，发了催稿信就回尽快。无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27538445056, createdName=ms7000000141590244, createdTime=Mon Jul 31 22:34:30 CST 2023, time=2023-07-31, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113643, encodeId=728b211364331, content=2022.11.10投稿，一直没处理，发了催稿邮件 2022.11.30终于开始under review 2022.12.27再次发邮件询问，说是只找到了一个审稿人，然后开始漫长地寻找第二个审稿人 2023.1.22说终于有第2个审稿人同意了，然而继续保持under review到今天…… 遥遥无期投稿路。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Wed Feb 08 18:30:26 CST 2023, time=2023-02-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097700, encodeId=3887209e700ef, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信+验证 经验分享：10.7投稿，过了查重 10.8等待编辑分配 10.14催了一次稿 10.21 under review 10.29 pending decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b818406818, createdName=ms5000000132216544, createdTime=Mon Oct 31 22:07:20 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104520, encodeId=8525210452062, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：一审3个月提了很多意见逐条修改之后变成小修，二审10天，现在终于被接受啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Dec 06 09:56:49 CST 2022, time=2022-12-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2097540, encodeId=0e6d209e5404c, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：催稿3次啦，还没给找编辑，这周还没有消息，打算撤稿啦，大家投慎重。听投过的说有8个月的撤稿过的小伙伴，太慢啦还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99215545970, createdName=Dream_happyer, createdTime=Mon Oct 31 07:41:47 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239598, encodeId=5f8d123959868, content=审稿快不快啊？怎么有些人说快，有些说很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Thu Aug 18 21:40:52 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227334, encodeId=8d41122e33488, content=偏重的研究方向：乳腺癌 经验分享：收纯临床回顾性分析文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Sun Jun 19 12:09:16 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216551, encodeId=a750121655110, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：请问这个杂志要上传原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=147136fam50暂无昵称, createdTime=Tue May 03 12:33:45 CST 2022, time=2022-05-03, status=1, ipAttribution=)]

2022-05-03 147136fam50暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：请问这个杂志要上传原始数据吗

32 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务